211 related articles for article (PubMed ID: 7987306)
1. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.
Crossey PA; Richards FM; Foster K; Green JS; Prowse A; Latif F; Lerman MI; Zbar B; Affara NA; Ferguson-Smith MA
Hum Mol Genet; 1994 Aug; 3(8):1303-8. PubMed ID: 7987306
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT
J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290
[TBL] [Abstract][Full Text] [Related]
3. Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Clinical Research Group for VHL in Japan.
Hum Mol Genet; 1995 Dec; 4(12):2233-7. PubMed ID: 8634692
[TBL] [Abstract][Full Text] [Related]
4. Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene.
Richards FM; Crossey PA; Phipps ME; Foster K; Latif F; Evans G; Sampson J; Lerman MI; Zbar B; Affara NA
Hum Mol Genet; 1994 Apr; 3(4):595-8. PubMed ID: 8069305
[TBL] [Abstract][Full Text] [Related]
5. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
[TBL] [Abstract][Full Text] [Related]
6. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
[TBL] [Abstract][Full Text] [Related]
8. Von Hippel-Lindau disease and endocrine tumour susceptibility.
Woodward ER; Maher ER
Endocr Relat Cancer; 2006 Jun; 13(2):415-25. PubMed ID: 16728571
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
[TBL] [Abstract][Full Text] [Related]
10. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G
Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.
Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK
Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic analysis of von Hippel-Lindau disease.
Richards FM; Webster AR; McMahon R; Woodward ER; Rose S; Maher ER
J Intern Med; 1998 Jun; 243(6):527-33. PubMed ID: 9681854
[TBL] [Abstract][Full Text] [Related]
13. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe.
Glavac D; Neumann HP; Wittke C; Jaenig H; Masek O; Streicher T; Pausch F; Engelhardt D; Plate KH; Höfler H; Chen F; Zbar B; Brauch H
Hum Genet; 1996 Sep; 98(3):271-80. PubMed ID: 8707293
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
[TBL] [Abstract][Full Text] [Related]
16. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
Chen F; Kishida T; Yao M; Hustad T; Glavac D; Dean M; Gnarra JR; Orcutt ML; Duh FM; Glenn G
Hum Mutat; 1995; 5(1):66-75. PubMed ID: 7728151
[TBL] [Abstract][Full Text] [Related]
18. Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma.
Losonczy G; Fazakas F; Pfliegler G; Komáromi I; Balázs E; Pénzes K; Berta A
BMC Med Genet; 2013 Jan; 14():3. PubMed ID: 23298237
[TBL] [Abstract][Full Text] [Related]
19. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM
Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911
[TBL] [Abstract][Full Text] [Related]
20. Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system.
Oberstrass J; Reifenberger G; Reifenberger J; Wechsler W; Collins VP
J Pathol; 1996 Jun; 179(2):151-6. PubMed ID: 8758206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]